Clinical Trials Browser

Prostatic Neoplasms

NCT06717295 2026-01-02

CCANED-CIPHER

CNSGastrointestinalGenitourinaryGynecologicThoracic

Pancreatic cancer, adult, Carcinoma, Non-Small-Cell Lung, Glioblastoma, Carcinoma, Hepatocellular, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT04566029 2025-12-10

AMI

Completed

40 enrolled

Genitourinary

Carcinoma, Transitional Cell

NCT03284684 2025-12-01

Periop ctDNA

Completed

30 enrolled

BreastGastrointestinalGenitourinary

Breast Neoplasms, Colonic Neoplasms, Prostatic Neoplasms

NCT03223727 2023-04-18

ROTOR

Completed

100 enrolled

Genitourinary

Prostate Cancer Metastatic

NCT02346526 2022-09-29

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

Phase 2 Completed

22 enrolled 14 charts

Genitourinary

Prostatic Neoplasms

NCT04113486 2020-11-24

ENRC

Unknown

400 enrolled

Genitourinary

Carcinoma, Renal Cell, Kidney Neoplasms

NCT04168788 2019-11-19

MVO

Phase NA Unknown

150 enrolled

Classical hematologyGenitourinaryLymphoidOther hematologic neoplasm

Hepatic Veno-Occlusive Disease, Wilms Tumor, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02109926 2018-05-11

TESTIS

Completed

1,367 enrolled

Genitourinary

Testicular Germ Cell Tumor

NCT02747563 2016-04-21

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Phase 1 Unknown

60 enrolled

Genitourinary

Prostatic Neoplasms

NCT00523471 2016-02-26

Blood Test to Measure DNA Damage in Blood

Terminated

40 enrolled

Genitourinary

Prostatic Neoplasms

NCT01838265 2014-12-08

MGM

Withdrawn

Genitourinary

Prostatic Neoplasms

Clinical Trials

FOCALE

CCANED-CIPHER

AMI

Periop ctDNA

ROTOR

A Biomarker Study of Standard-of-care Radium-223 Chloride for Metastatic Castration-resistant Prostate Cancer

ENRC

MVO

TESTIS

Evaluation of PSA Blood Levels Prior to and After Digital Rectal Examination

Blood Test to Measure DNA Damage in Blood

MGM